111 And Scrianen Forge Strategic Partnership To Enhance Drug Supply And Accessibility Across China
Portfolio Pulse from Benzinga Newsdesk
111, Inc. has announced a strategic direct supply partnership with Beijing Scrianen Pharmaceutical Co., Ltd. to enhance drug supply and accessibility across China.
June 11, 2024 | 8:24 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
111, Inc. has entered into a strategic partnership with Beijing Scrianen Pharmaceutical to enhance drug supply and accessibility across China.
The partnership is likely to positively impact 111, Inc. by expanding its drug supply chain and improving accessibility, which could lead to increased revenues and market presence in China.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100